Radiation boost may improve immunotherapy for advanced esophageal cancer
NCT ID NCT05978193
First seen Jan 24, 2026 · Last updated May 18, 2026 · Updated 14 times
Summary
This study tests whether adding low-dose or standard radiation to the usual combination of immunotherapy and chemotherapy can better control metastatic esophageal squamous cell carcinoma. About 100 adults with stage IVB cancer who have not had prior treatment will participate. The goal is to see if the triple therapy improves how long the cancer stays under control and is safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Chest Hospital
RECRUITINGShanghai, 200030, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shanghai Ruijin Hospital
RECRUITINGShanghai, 200020, China
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.